Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients

Journal of Korean Medical Science - Tập 34 Số 2
Jae‐Hoon Song1, Si‐Ho Kim1, Cheol‐In Kang1, Sun Young Cho1, Nam Yong Lee2, Doo Ryeon Chung1, Kyong Ran Peck1, Jae‐Hoon Song1
1Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

Barlam, 2016, Clin Infect Dis, 62, e51, 10.1093/cid/ciw118

Freifeld, 2011, Clin Infect Dis, 52, e56, 10.1093/cid/cir073

Cha, 2015, Antimicrob Agents Chemother, 59, 5834, 10.1128/AAC.01121-15

Park, 2016, Ann Intern Med, 165, 87, 10.7326/M15-2495

Huh, 2016, Am J Infect Control, 44, e145, 10.1016/j.ajic.2016.01.025

Chang, 2017, Int J Antimicrob Agents, 49, 734, 10.1016/j.ijantimicag.2017.01.030

Park, 2017, Infect Chemother, 49, 184, 10.3947/ic.2017.49.3.184

Kim, 2017, BMC Infect Dis, 17, 500, 10.1186/s12879-017-2597-0

Morgan, 2010, Infect Control Hosp Epidemiol, 31, 716, 10.1086/653201

Falagas, 2006, J Hosp Infect, 64, 7, 10.1016/j.jhin.2006.04.015

Choi, 2010, J Korean Med Sci, 25, 999, 10.3346/jkms.2010.25.7.999

Thông tin
Thông tin xuất bản

Journal of Korean Medical Science

Tập 34 Số 2

Thông tin tác giả